3 ms·
The average risk of thrombosis the J&J and AstraZeneca vaccine have are between 1 in 100,000 to 1 in 250,000. To put some perspective, estrogen-based medication
by m-p-3 6y ago
The average risk of thrombosis the J&J and AstraZeneca vaccine have are between 1 in 100,000 to 1 in 250,000.
To put some perspective, estrogen-based medication like the contraceptive pill have a risk of 1 in 1,000.
- mikem170 6y agoCareful, You might be comparing apples and oranges... Contraceptive pill blood clot risk is for any type of blood clot, such as deep vein thrombosis, pulmonary embolism, etc [0]. The vaccine cerebral venous sinus thrombosis blood clot risk is something like 1 in 100k+ (as you mentioned), but during J&J FDA trials of 20k people there were 50% more blood clots of other various types in the vaccinated group [1] (15 blood clots in vaccinated group versus 10 in the placebo group, which the FDA did not consider statistically significant at the time) You may be comparing fatal-only vaccine blood clots to non-fatal contraception blood clots, and ignoring non-fatal vaccine blood clots. I'm not saying this to throw the vaccine under the bus, just pointing out that the comparison of the odds you presented might not be fair. [0] https://thefemedic.com/contraception/blood-clots-thrombosis-combined-contraceptive-pill/ https://thefemedic.com/contraception/blood-clots-thrombosis-... [1] https://www.cnn.com/2021/04/13/health/johnson-vaccine-blood-clots-cdc-fda/index.html https://www.cnn.com/2021/04/13/health/johnson-vaccine-blood-...
- mlyle 6y ago> You may be comparing fatal-only vaccine blood clots to non-fatal contraception blood clots At the time vaccination was paused, here were 6 known cases of CVST, 2 fatal, in 6.8 million vaccinated. To come up with 1 in 250,000 like the OP, you need to consider only women (~3.5 million doses), count all cases (not just the fatalities), and assume more than half of the cases were not reported.